Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
Featured trial
A phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherapy administered to adult patients with moder-to-severe atopic dermatitis

A phase 3 confirmatory study investigating the efficacy and safety of dupilumab monotherapy administered to adult patients with moder-to-severe atopic dermatitis

  • 102 views
  • 08 Nov, 2020
  • 1 location
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)

Primary Objective: To evaluate the ability of dupilumab to reduce the need for rescue therapy with systemic corticosteroids (SCS) or surgery of AFRS in patients with AFRS who

  • 8 views
  • 04 Oct, 2022
  • 39 locations
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis

The primary objective of the study is to evaluate the efficacy of dupilumab on the annualized rate of exacerbations in participants with Allergic Bronchopulmonary Aspergillosis (ABPA).

  • 38 views
  • 23 Sep, 2022
  • 66 locations
Cholinergic Urticaria - Efficacy of Dupilumab (CHED)

The purpose of this study is to assess the efficacy in reducing disease activity and safety of Dupilumab in adult patients with cholinergic urticarial (CholU) who are symptomatic despite H1

  • 69 views
  • 29 May, 2022
  • 7 locations
Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis

The investigators will investigate the efficacy of dupilumab in patients with severe eosinophilic CRSsNP who are resistant to the conventional treatment with intranasal corticosteroids and have

  • 2 views
  • 16 Aug, 2021
  • 1 location
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the efficacy of Dupilumab in the treatment of signs and

  • 0 views
  • 28 Feb, 2022
  • 13 locations
Dupilumab for Prevention of Recurrence of CRSwNP After ESS

The investigators believe that administering Dupilumab during the pre- and peri-operative period of surgery for chronic rhinosinusitis with nasal polyps (CRSwNP) will safely downregulate Type 2

  • 1 views
  • 13 Jun, 2021
  • 1 location
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)  

Primary Objective: To evaluate the ability of dupilumab to reduce the need for rescue therapy with systemic corticosteroids (SCS) or surgery of AFRS in patients with AFRS who

  • 58 views
  • 04 Oct, 2022
  • 1 location
Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis

medications including proton pump inhibitors, topical steroids or biologics. Food elimination creates a decrease quality of life in many children. The goal of the study is to examine a T2 inhibitor (dupilumab

  • 0 views
  • 18 Sep, 2022
  • 1 location
Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy

objective is to assess whether dupilumab as an adjunct to milk oral immunotherapy (OIT) compared to placebo improves the safety of milk OIT and rates of desensitization, defined as an increase in the

  • 0 views
  • 11 Nov, 2021
  • 3 locations